Michel Gonzalez Selected Research

Segmental Mastectomy (Lumpectomy)

2/2024	Segmentectomy for lung cancer: Dig deeper.
2/2023	Local control and short-term outcomes after video-assisted thoracoscopic surgery segmentectomy versus lobectomy for pT1c pN0 non-small-cell lung cancer.
1/2023	European Society of Thoracic Surgeons expert consensus recommendations on technical standards of segmentectomy for primary lung cancer.
1/2022	Ventilatory efficiency slope is associated with cardiopulmonary complications after thoracoscopic anatomical lung resection.
1/2021	Short-term local control after VATS segmentectomy and lobectomy for solid NSCLC of less than 2 cm.
6/2020	Uniportal ligamentum-based approach to posterolateral segments 9 and 10.
11/2019	Comparison of postoperative complications between segmentectomy and lobectomy by video-assisted thoracic surgery: a multicenter study.
10/2019	Impact of complex segmentectomies by video-assisted thoracic surgery on peri-operative outcomes.
10/2018	An enhanced recovery after surgery program for video-assisted thoracoscopic surgery anatomical lung resections is cost-effective.
8/2018	Clinical outcome and risk factors for complications after pulmonary segmentectomy by video-assisted thoracoscopic surgery: results of an initial experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Gonzalez Research Topics

Disease

16	Neoplasm Metastasis (Metastasis) 02/2023 - 02/2012
15	Neoplasms (Cancer) 04/2024 - 04/2012
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 12/2012
8	Lung Neoplasms (Lung Cancer) 02/2024 - 07/2013
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2012
5	Fistula 01/2018 - 08/2012
4	Mesothelioma 10/2020 - 04/2012
3	Malignant Mesothelioma 04/2024 - 08/2012
3	Sarcoma (Soft Tissue Sarcoma) 02/2016 - 04/2012
3	Pneumothorax 01/2016 - 09/2010
3	Empyema 03/2015 - 08/2012
2	Respiratory Insufficiency (Respiratory Failure) 05/2022 - 02/2016
2	Inflammation (Inflammations) 01/2021 - 01/2020
2	Lung Diseases (Lung Disease) 01/2020 - 04/2011
2	Aspergillosis 12/2013 - 08/2012
2	Infections 12/2013 - 05/2011
1	Postoperative Nausea and Vomiting (PONV) 04/2024
1	COVID-19 11/2022
1	Pain (Aches) 09/2022
1	Hemoptysis 05/2022
1	Pleural Empyema (Pyothorax) 05/2022
1	Lymphatic Metastasis 01/2022
1	Ischemia 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Pulmonary Alveolar Proteinosis 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Edema (Dropsy) 01/2020
1	Lung Injury 01/2020
1	Pulmonary Atelectasis 11/2019
1	Wounds and Injuries (Trauma) 07/2019
1	Wound Infection (Wound Infections) 07/2019
1	Vomiting 01/2019
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2019
1	Nausea 01/2019
1	Hereditary renal agenesis 01/2019
1	Venous Thromboembolism 01/2019
1	Hypothermia 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Necrosis 01/2018
1	Tracheal Diseases 01/2018

Drug/Important Bio-Agent (IBA)

6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019 - 04/2012
3	fluorescein isothiocyanate dextranIBA 01/2019 - 08/2012
2	Hypnotics and Sedatives (Sedatives)IBA 04/2024 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 10/2017
2	Carcinoembryonic AntigenIBA 01/2018 - 02/2013
2	lipoplatinIBA 10/2017 - 04/2015
2	liposomal doxorubicin (Doxil)FDA Link 05/2014 - 04/2012
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2024
1	Drinking WaterIBA 04/2024
1	Volatile Fatty AcidsIBA 04/2024
1	catch-relaxing peptide (Mytilus)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 10/2021
1	durvalumabIBA 10/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	3-aminobenzamideIBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018

Therapy/Procedure

13	Metastasectomy 02/2023 - 02/2012
10	Segmental Mastectomy (Lumpectomy) 02/2024 - 08/2018
10	Drug Therapy (Chemotherapy) 03/2023 - 07/2013
8	Pneumonectomy (Lung Volume Reduction) 01/2018 - 03/2011
6	Photochemotherapy (Photodynamic Therapy) 10/2020 - 04/2012
5	Therapeutics 09/2022 - 05/2011
3	Chest Tubes (Chest Tube) 01/2016 - 08/2012
2	Radiotherapy 03/2023 - 10/2021
2	Length of Stay 05/2022 - 07/2019
2	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 11/2019
2	Lung Transplantation 01/2021 - 04/2011
2	Transplantation 01/2018 - 12/2013
2	Debridement 03/2015 - 05/2011
2	Chemoradiotherapy 07/2013 - 12/2012
2	Negative-Pressure Wound Therapy 05/2013 - 05/2011
2	Thoracostomy 08/2012 - 05/2011
1	Thoracotomy 04/2024
1	Antibiotic Prophylaxis 04/2024
1	Anesthesia 04/2024
1	Immunotherapy 04/2024
1	Induction Chemotherapy 03/2023
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 11/2022
1	Operative Time 06/2022
1	Neoadjuvant Therapy 10/2021
1	Enhanced Recovery After Surgery 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Warm Ischemia 01/2020
1	Sternotomy 07/2019
1	Early Ambulation 01/2019
1	Carbohydrate Loading Diet 01/2019
1	Urinary Catheters 01/2019
1	Preoperative Exercise 01/2019
1	Analgesia 01/2019
1	Minimally Invasive Surgical Procedures 01/2019